Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ARS Pharmaceuticals Inc (SPRY)

  • Business News
  • Nov. 03, 2025, 12:45 UTC
  • 16
  • 1 comments

ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

Market reaction Comment Full text

Curaleaf Hldgs Inc. (CURLF)

  • Business News
  • Nov. 03, 2025, 12:45 UTC
  • 16
  • 1 comments

Curaleaf Launches Fifth Annual Feed the Block Fundraiser to Combat Food Insecurity Across the U.S.

Market reaction Comment Full text

BridgeBio Pharma (BBIO)

  • Business News
  • Nov. 03, 2025, 12:30 UTC
  • 14
  • 1 comments

BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025

Market reaction Comment Full text

Cybin Inc (CYBN)

  • Business News
  • Nov. 03, 2025, 12:30 UTC
  • 17
  • 1 comments

Cybin to Participate at the 2025 Milken Institute Future of Health Summit

Market reaction Comment Full text

Biogen Inc (BIIB)

  • Business News
  • Nov. 03, 2025, 12:30 UTC
  • 16
  • 1 comments

Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025

Market reaction Comment Full text

Abeona Therapeutics Inc. (ABEO)

  • Business News
  • Nov. 03, 2025, 12:30 UTC
  • 13
  • 1 comments

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

InspireMD Inc (NSPR)

  • Business News
  • Nov. 03, 2025, 12:30 UTC
  • 15
  • 1 comments

InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer

Market reaction Comment Full text

Altimmune Inc (ALT)

  • Business News
  • Nov. 03, 2025, 12:30 UTC
  • 12
  • 1 comments

Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder

Market reaction Comment Full text

Dyne Therapeutics Inc (DYN)

  • Business News
  • Nov. 03, 2025, 12:30 UTC
  • 16
  • 1 comments

Dyne Therapeutics to Present at Upcoming Investor Conferences

Market reaction Comment Full text

Foghorn Therapeutics Inc (FHTX)

  • Business News
  • Nov. 03, 2025, 12:30 UTC
  • 13
  • 1 comments

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

Market reaction Comment Full text
  • Previous
  • 917
  • 918
  • 919
  • 920
  • 921
  • Next

Search

News categories

  • Technical Exchange News(11010)
  • Event(2495)
  • SEC News(195070)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126810)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin